AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Jan 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-01-10

Reporting Person: Campbell Bradley L (Director, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-10	Common Stock	A	59881	—	Acquired	405076	Direct
2020-01-10	Common Stock	F	29492	$9.46	Disposed	375584	Direct

Footnotes

F1: Granted for the achievement of the 2017 PRSU TSR goal as determined by the Compensation Committee of the Board of Directors.